Anti-thrombotic Activity of Phenolic Acids Obtained from Salvia Miltiorrhiza F. Alba in TNF-α-stimulated Endothelial Cells Via the NF-κB/JNK/p38 MAPK Signaling Pathway

Overview

Journal Arch Pharm Res

Specialty Pharmacology

Date 2021 Apr 13

PMID 33847919

Citations 12

Authors

Xianjing Zheng

Haimei Liu

Maoqiang Ma

Jianbo Ji

Faliang Zhu

Longru Sun

Affiliations

Soon will be listed here.

Abstract

Over the past 100 years, Salvia miltiorrhiza f. alba (Lamiaceae) (RSMA) roots have been used to cure thromboangiitis obliterans (TAO) in local clinics. This study aimed to confirm the anti-thrombotic efficacy of 12 phenolic acids obtained from RSMA and to clarify the possible underlying mechanisms. The results of quantitative real-time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) experiments demonstrated that most of the phenolic acids markedly inhibited PAI-1 protein and mRNA levels but increased t-PA protein and mRNA levels in TNF-α-induced EA.hy926 cells (P < 0.05 or 0.001), with lithospermic acid displaying the strongest effect. In vitro anticoagulation and antiplatelet aggregation assays showed that lithospermic acid and salvianolic acid B significantly prolonged prothrombin time (PT), activated partial thromboplastin time (APTT), decreased fibrinogen concentration (FIB), and inhibited platelet aggregation induced by adenosine diphosphate (ADP) in rat blood. Both lithospermic acid and salvianolic acid B markedly down-regulated the expression of factor Xa and factor IIa on the external surface of EA.hy926 cells and demonstrated significant anti-factor IIa and anti-factor Xa activity using chromogenic substrates in vitro. Western blot results revealed that both lithospermic acid and salvianolic acid B also significantly inhibited the expression of TF, p-p65, p-p38, and pJNK proteins induced by TNF-α. These results indicated that all of the phenolic acids appeared to have some anti-thrombotic activity, with salvianolic acid B and lithospermic acid markedly decreasing the chance of thrombosis by regulating the NF-κB/JNK/p38 MAPK signaling pathway in response to TNF-α.

Citing Articles

Role of salvianolic acid B in the treatment of acute ischemic stroke: a systematic review and meta-analysis of animal models.

Wang J, Su P, Wan C, Xu Y, Huang J, Niu J Front Pharmacol. 2025; 15():1479765.

PMID: 39776581 PMC: 11705389. DOI: 10.3389/fphar.2024.1479765.

TLR2 promotes traumatic deep venous thrombosis of the lower extremity following femoral fracture by activating the NF‑κB/COX‑2 signaling pathway in rats.

Guo T, Xiong L, Xie J, Zeng J, Huang Z, Yao M Exp Ther Med. 2024; 28(6):436.

PMID: 39355523 PMC: 11443593. DOI: 10.3892/etm.2024.12725.

Assessment of antioxidant and antibacterial efficacy of some indigenous vegetables consumed by the Manipuri community in Sylhet, Bangladesh.

Roy M, Shourove J, Singha R, Tonmoy T, Chandra Biswas G, Meem F Heliyon. 2024; 10(18):e37750.

PMID: 39315213 PMC: 11417267. DOI: 10.1016/j.heliyon.2024.e37750.

Natural Phenolic Compounds with Antithrombotic and Antiplatelet Effects: A Drug-likeness Approach.

Fernandes D, Gomes A, da Silva C, de Medeiros Henriques I, Barros de Menezes R, Scotti M Curr Med Chem. 2024; 31(26):4138-4159.

PMID: 38375850 DOI: 10.2174/0109298673268452231108061008.

Research progress of NF-κB signaling pathway and thrombosis.

Wang Z, Fang C, Yao M, Wu D, Chen M, Guo T Front Immunol. 2023; 14:1257988.

PMID: 37841272 PMC: 10570553. DOI: 10.3389/fimmu.2023.1257988.

References

Amiral J, Laroche M, Seghatchian J . A new assay for global fibrinolysis capacity (GFC): Investigating a critical system regulating hemostasis and thrombosis and other extravascular functions. Transfus Apher Sci. 2018; 57(1):118-126. DOI: 10.1016/j.transci.2018.02.020. View

Eden D, Panagiotou G, Mokhtari D, Eriksson J, Aberg M, Siegbahn A . Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner. Ups J Med Sci. 2019; 124(3):158-167. PMC: 6758637. DOI: 10.1080/03009734.2019.1645248. View

Fan H, Fu F, Yang M, Xu H, Zhang A, Liu K . Antiplatelet and antithrombotic activities of salvianolic acid A. Thromb Res. 2010; 126(1):e17-22. DOI: 10.1016/j.thromres.2010.04.006. View

Fanjul-Fernandez M, Folgueras A, Cabrera S, Lopez-Otin C . Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta. 2009; 1803(1):3-19. DOI: 10.1016/j.bbamcr.2009.07.004. View

Fei Y, Wang S, Yang L, Qiu Y, Li Y, Liu W . Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats. J Ethnopharmacol. 2017; 207:57-66. DOI: 10.1016/j.jep.2017.06.023. View

Hanslik A, Kitzmuller E, Tran U, Thom K, Karapetian H, Prutsch N . Anti-activated factor II assay for monitoring unfractionated heparin in children: results of the HEARTCAT study. J Thromb Haemost. 2016; 15(1):38-46. DOI: 10.1111/jth.13539. View

Hsu T, Young M, Cmarik J, Colburn N . Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med. 2000; 28(9):1338-48. DOI: 10.1016/s0891-5849(00)00220-3. View

Huebner B, Moore E, Moore H, Stettler G, Nunns G, Lawson P . Thrombin Provokes Degranulation of Platelet α-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1). Shock. 2017; 50(6):671-676. PMC: 6019632. DOI: 10.1097/SHK.0000000000001089. View

Koupenova M, Clancy L, Corkrey H, Freedman J . Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis. Circ Res. 2018; 122(2):337-351. PMC: 5777300. DOI: 10.1161/CIRCRESAHA.117.310795. View

10.

Kovacs B, Bereczky Z, Olah Z, Gindele R, Kerenyi A, Selmeczi A . The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency. Am J Clin Pathol. 2013; 140(5):675-9. DOI: 10.1309/AJCPVY4Z9XZMFOTH. View

11.

Ku S, Yoon E, Lee W, Kwon S, Lee T, Bae J . Antithrombotic and antiplatelet activities of pelargonidin in vivo and in vitro. Arch Pharm Res. 2016; 39(3):398-408. DOI: 10.1007/s12272-016-0708-x. View

12.

Lee W, Lee J, Kulkarni R, Kim M, Hwang J, Na M . Antithrombotic and antiplatelet activities of small-molecule alkaloids from Scolopendra subspinipes mutilans. Sci Rep. 2016; 6:21956. PMC: 4764974. DOI: 10.1038/srep21956. View

13.

Liu H, Ma S, Xia H, Lou H, Zhu F, Sun L . Anti-inflammatory activities and potential mechanisms of phenolic acids isolated from Salvia miltiorrhiza f. alba roots in THP-1 macrophages. J Ethnopharmacol. 2018; 222:201-207. DOI: 10.1016/j.jep.2018.05.008. View

14.

Lopes-Bezerra L, Filler S . Endothelial cells, tissue factor and infectious diseases. Braz J Med Biol Res. 2003; 36(8):987-91. DOI: 10.1590/s0100-879x2003000800004. View

15.

Nar H, Bauer M, Schmid A, Stassen J, Wienen W, Priepke H . Structural basis for inhibition promiscuity of dual specific thrombin and factor Xa blood coagulation inhibitors. Structure. 2001; 9(1):29-37. DOI: 10.1016/s0969-2126(00)00551-7. View

16.

Obermayer G, Afonyushkin T, Binder C . Oxidized low-density lipoprotein in inflammation-driven thrombosis. J Thromb Haemost. 2018; 16(3):418-428. DOI: 10.1111/jth.13925. View

17.

Rauch U, Osende J, Fuster V, Badimon J, Fayad Z, Chesebro J . Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med. 2001; 134(3):224-38. DOI: 10.7326/0003-4819-134-3-200102060-00014. View

18.

Sioulis A, Malindretos P, Makedou A, Makris P, Grekas D . Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients. Hippokratia. 2009; 13(4):237-41. PMC: 2776338. View

19.

Tsantarliotou M, Lavrentiadou S, Psalla D, Margaritis I, Kritsepi M, Zervos I . Suppression of plasminogen activator inhibitor-1 (PAI-1) activity by crocin ameliorates lipopolysaccharide-induced thrombosis in rats. Food Chem Toxicol. 2019; 125:190-197. DOI: 10.1016/j.fct.2019.01.001. View

20.

Ulfhammer E, Larsson P, Karlsson L, Hrafnkelsdottir T, Bokarewa M, Tarkowski A . TNF-alpha mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-kappaB- and p38 MAPK-dependent. J Thromb Haemost. 2006; 4(8):1781-9. DOI: 10.1111/j.1538-7836.2006.02035.x. View